Life Stem Genetics, Inc. engages in the operation of stem cell therapy-based clinics. The company is headquartered in Beverly Hills, California and currently employs 1 full-time employees. The company went IPO on 2013-04-11. The firm is exploring to engage in cell therapy research and life science in general.
LIFS stock price ended at $0 on 木曜日, after rising NaN%
On the latest trading day Jul 23, 2026, the stock price of LIFS rose by NaN%, climbing from $0.00 to $0.00. Throughout the session, the stock experienced a volatility of NaN%, with prices fluctuating between a daily low of $0.00 and a high of $0.00. Alongside this price increase, trading volume also rose by 300 shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 200 shares were traded, amounting to a market value of approximately --.